Abstract
Despite the known benefits, antiretroviral therapy (HAART), used by patients seropositive for HIV, leads to a redistribution of fat and metabolic alterations that increase the risk for development of insulin resistance and consequently diabetes. Therefore, it is essential that such risks are identified early through safe and feasible methods. Goals: To assess the prevalence of insulin res…